Rose Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

With AE Reporting Push, FDA Emphasizes Importance Of Cosmetic Safety

Executive Summary

FDA hopes a campaign promoting its adverse event reporting program for cosmetics will lead to increased consumer participation, which could put further pressure on industry to ensure the safety of their products.
Advertisement

Related Content

Cosmetic Adverse Event Reports Spiked 56% In Fiscal 2014 – FDA
FDA Cosmetics Update: 2013 AE Reports Tallied, 2014 Research Targeted
Cosmetics Adverse Events Reported To FDA Increase 35% In FY 2012
In Brief
Formaldehyde Frenzy: EWG Calls For FDA Action, OSHA Advises Against Use
In Brief
FDA Emphasizes Cosmetics Safety, But Lowers Funding In Budget Request
Council Proposes "Modernized" FDA Oversight Of Personal-Care Industry
Council Proposes "Modernized" FDA Oversight Of Personal-Care Industry
FDA Requests $9 Mil. To Educate Consumers On AE Cosmetics Reporting
Advertisement
UsernamePublicRestriction

Register

RS017522

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel